- $390.63m
- $521.43m
- $822.31m
Brief: Orthofix Medical Q2 Sales USD 198.6 Million Vs. IBES Estimate USD 195.2 Million
Orthofix Medical Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Orthofix Announces 510(K) Clearance And First Implant Of Fitbone Transport And Lengthening System
Orthofix Medical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Orthofix Medical Q1 Sales USD 188.6 Million Vs. IBES Estimate USD 184.1 Million
Orthofix Medical Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Orthofix Reports Fourth Quarter And Full Year 2023 Results
Brief: Orthofix Medical Q4 Gross Margin 68.2%
Orthofix Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Orthofix Announces New President for Bone Growth Therapies Business
Brief: Orthofix Announces Commercial Partnership With Mriguidance
Brief: Julie Andrews Begins As New Chief Financial Officer At Orthofix
Brief: Orthofix Medical Announces Preliminary 2023 Q4 And FY Results
Brief: Orthofix Appoints Julie Andrews As Chief Financial Officer
Brief: Orthofix Announces Agreement With Engine Capital And Appointment Of Three New Independent Directors
Uber gains as stock set to join S&P 500
Brief: Orthofix Names Massimo Calafiore As President, Chief Executive Officer
Brief: Orthofix Announces Leadership Changes
Brief: Orthofix Announces First Cases And Full Commercial Launch Of The 7D Flash Navigation System Percutaneous Module 2.0 For Minimally Invasive Surgery